BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
4420932
Number of visits today
1162
Number of downloads
4057373
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Muto Y, Okuma Y. Therapeutic options in thymomas and thymic carcinomas. Expert Rev Anticancer Ther 2022. [PMID: 35266421 DOI: 10.1080/14737140.2022.2052278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Z, Lu Y, Gu Z, Sun Q, Fang W, Yan W, Ku X, Liang Z, Hu G. HNRNPA2B1 as a potential therapeutic target for thymic epithelial tumor recurrence: An integrative network analysis. Comput Biol Med 2023;155:106665. [PMID: 36791552 DOI: 10.1016/j.compbiomed.2023.106665] [Reference Citation Analysis]
2 Ruggeri RM, Benevento E, De Cicco F, Fazzalari B, Guadagno E, Hasballa I, Tarsitano MG, Isidori AM, Colao A, Faggiano A; NIKE Group. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies. J Endocrinol Invest 2023;46:213-34. [PMID: 36038743 DOI: 10.1007/s40618-022-01905-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345